Lv11
10 积分 2023-09-27 加入
Safety and Efficacy Intravenous Istaroxime up to 60 hours for Patients with Pre-Cardiogenic Shock
1小时前
求助中
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre-Cardiogenic Shock
1小时前
已完结
Istaroxime: A Novel Therapeutic Agent for Acute Heart Failure
7天前
已完结
[Efficacy and safety of alirocumab versus ezetimibe in high cardiovascular risk Chinese patients with hyperlipidemia: ODYSSEY EAST Study-Chinese sub-population analysis]
21天前
已完结
Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data
24天前
已完结
Efficacy of Levosimendan in the Treatment of Patients With Severe Septic Cardiomyopathy
1个月前
已完结
The cost‐utility and budget impact analyses of Tirzepatide versus once‐weekly Semaglutide as add‐on therapy to metformin in patients with type 2 diabetes mellitus in China
1个月前
已完结
Ketamine for Critically Ill Patients with Severe Acute Brain Injury: A Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials
2个月前
已完结
The association between pain, analgesia, and delirium among critically ill adults: a systematic review and meta-analysis
2个月前
已完结
Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
3个月前
已关闭
皖公网安备34019202002308
